SPORE
-
STINGing combination for cancer
A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer. Read MoreJun 19, 2017
-
New direction for treating lung cancer
Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer. Read MoreFeb 7, 2014
-
Vanderbilt, GE unite to study colon tumor development
Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop. Read MoreJan 31, 2013
-
Vanderbilt identifies genes linked to breast cancer chemo resistance
A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. Read MoreJun 11, 2012